Filing Details

Accession Number:
0001209191-10-055500
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-17 16:19:22
Reporting Period:
2010-11-15
Filing Date:
2010-11-17
Accepted Time:
2010-11-17 16:19:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949858 Oncogenex Pharmaceuticals Inc. OGXI In Vitro & In Vivo Diagnostic Substances (2835) 954343413
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1442675 Daniel Scott Cormack 400-1001 W. Broadway
Vancouver A1 V6H 4B1
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-15 5,000 $3.89 13,092 No 4 M Indirect Spouse
Common Stock Disposition 2010-11-15 5,000 $15.99 8,092 No 4 S Indirect Spouse
Common Stock Acquisiton 2010-11-16 5,000 $3.89 18,067 No 4 M Direct
Common Stock Disposition 2010-11-16 5,000 $0.00 13,067 No 4 G Direct
Common Stock Acquisiton 2010-11-16 5,000 $0.00 30,680 No 4 G Indirect By Trycor Investment Trust No. 1
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect Spouse
No 4 S Indirect Spouse
No 4 M Direct
No 4 G Direct
No 4 G Indirect By Trycor Investment Trust No. 1
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common stock option Disposition 2010-11-15 5,000 $0.00 5,000 $3.89
Common Stock Option Disposition 2010-11-16 5,000 $0.00 5,000 $3.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,533 2003-12-16 2010-12-16 No 4 M Indirect
3,709 2006-12-16 2010-12-16 No 4 M Direct
Footnotes
  1. Scott D. Cormack and his spouse are the trustees and beneficiaries of the Trycor Investment Trust No. 1
  2. These shares were exercised and sold under the 10b5 Sales Plan.